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 2 
Abstract  1 
HSV-2 spread is predominantly dependent on cell-to-cell contact. However, the 2 
underlying mechanisms remain to be determined. Here we demonstrate that HSV-2 gJ, 3 
which was previously assigned no specific function, promotes HSV-2 cell-to-cell spread 4 
and syncytia formation. In the context of viral infection, knockout or knockdown of gJ 5 
impairs HSV-2 cell-to-cell spread among epithelial cells or from epithelial cells to 6 
neuronal cells, which leads to decreased virus production, whereas ectopic expression of 7 
gJ enhances virus production. Mechanistically, gJ increases the expression levels of 8 
HSV-2 proteins, and also enhances viral protein expression and replication of 9 
heterologous viruses like HIV-1 and JEV, suggesting that HSV-2 gJ likely functions as a 10 
regulator of viral protein expression and virus production. Findings in this study provide 11 
a basis for further understanding the role of gJ in HSV-2 replication.  12 
 13 
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 3 
Introduction 1 
HSV-2, a typical member of the α-herpesvirus subfamily, can infect the epithelium to 2 
cause genital herpes, establish latency in peripheral nervous system and be transmitted to 3 
the central nervous system, leading to a life-long latent infection (RC., 2001). HSV-2 4 
infection also increases the risk of HIV-1 acquisition and transmission (Baeten et al., 5 
2004; Freeman et al., 2006). The outermost envelope of HSV-2 virion contains at least 12 6 
envelope glycoproteins which play important roles during the process of viral 7 
entry/egress and cell-to-cell spread (Haarr and Skulstad, 1994). In addition to viral 8 
essential proteins, the functions of many non-essential proteins of HSV-1/HSV-2 which 9 
are dispensable for virus replication (Baines and Roizman, 1991; Balan et al., 1994) have 10 
been revealed gradually. For example, the complex of gE and gI of HSV-1 acts as a 11 
receptor for immunoglobulin G (IgG) (Bell et al., 1990; Hanke et al., 1990; Johnson et al., 12 
1988), facilitates efficient neuron-to-neuron transmission through synaptically linked 13 
neuronal pathways (Dingwell et al., 1995), and promotes cell-to-cell spread in vivo and 14 
across junctions of cultured cells (Dingwell et al., 1994). As the first viral 15 
chemokine-binding protein described, secreted HSV-1/HSV-2 gG has been shown to 16 
enhance chemokine function through modulation of receptor trafficking and 17 
oligomerization, to mediate the interaction between HSV-1/HSV-2 particles and a specific 18 
set of human chemokines (Martinez-Martin et al., 2016; Martinez-Martin et al., 2015; 19 
Viejo-Borbolla et al., 2012), and to modify NGF-TrkA signaling to attract free nerve 20 
endings to the site of infection (Cabrera et al., 2015). HSV-1 gM potently restricts HIV-1 21 
by preventing intracellular transport and processing of Env gp160 (Polpitiya Arachchige 22 
et al., 2018) and partners with gN to modulate the viral fusion machinery (El Kasmi and 23 
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 4 
Lippe, 2015). Furthermore, HSV-1 gM and the gK/pUL20 complex have been shown to 1 
be important for the localization of gD and gH/L to viral assembly sites (Lau and Crump, 2 
2015).  3 
 4 
The documented new functions of these previously thought nonessential proteins are 5 
constantly refreshing our cognizance of HSV-1/HSV-2 and may have important 6 
implications for the rational design of potent antiviral strategies. HSV-2 gJ is a 92-amino 7 
acid late gene product encoded by the US5 open reading frame (ORF) (2), and so far has 8 
been assigned no specific function. Its orthologs HSV-1 gJ was thought to be a 9 
nonessential protein, and later found to inhibit apoptosis (22-25) and induce the formation 10 
of reactive oxygen species (26). Given that the aligned pairs of protein-coding regions for 11 
all genes (except US4, which in HSV-1 is grossly truncated) are around 83% sequence 12 
identity between HSV-1 and HSV-2 (Davison, 2011; Dolan et al., 1998), it is speculated 13 
that HSV-2 gJ may have a similar function as HSV-1 gJ.  14 
 15 
In this study, we investigated the function of HSV-2 gJ in the context of viral infection. 16 
Our results indicate that HSV-2 gJ knockout or knockdown impairs plaque and syncytia 17 
formation which leads to decreased virus production, while ectopic expression of gJ 18 
enhances virus production. Furthermore, gJ increases the expression levels of other 19 
HSV-2 proteins and also enhances viral protein expression and replication of 20 
heterologous viruses like HIV-1 and JEV. Although we cannot rule out other possible 21 
mechanisms, our data together indicate that HSV-2 gJ likely functions as a regulator of 22 
viral protein expression. This is the first time that HSV-2 gJ has been shown to increase 23 
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 5 
viral protein expression and virus production, which consequently promotes HSV-2 1 
cell-to-cell spread and syncytia formation. 2 
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Materials and Methods 1 
Ethic statement 2 
All protocols involving human subjects were reviewed and approved by the Local 3 
Research Ethics Committee. Informed written consents from the human subjects were 4 
obtained in this study.  5 
 6 
Antibodies, plasmids and shRNAs  7 
Mouse monoclonal antibody against FLAG was purchased from Sigma (F1804). Mouse 8 
monoclonal antibody against β-actin (sc-81178), rabbit polyclonal antibody against GFP 9 
(sc-8334), mouse monoclonal antibody against HSV-2 gD (sc-58154) were obtained from 10 
Santa Cruz. Mouse monoclonal antibody against HSV-2 gG (SAB4700764) was 11 
purchased from Sigma. Sheep polyclonal antibody against HSV-2 (PAB13979) was 12 
purchased from Abnova. Mouse monoclonal antibody against HSV-1+HSV-2 gB 13 
(ab6506) was purchased from Abcam.  14 
 15 
The ORF of gJ with flag tag fused to the C-terminal was cloned into pcDNA3.1(+) 16 
(named pgJ-flag). The ORFs of immediate early proteins ICP0, ICP22 and ICP27 with 17 
flag tag fused to the C-terminal were cloned into pcDNA3.1(+), named pICP0-flag, 18 
pICP22-flag and pICP27-flag, respectively. The ORF of glycoproteins gB and gL with 19 
flag tag were cloned into pcDNA3.1(+) (named pgB and pgL-flag, respectively). All 20 
constructs were verified by DNA sequencing (Sunny Biotechnology Co. Ltd, Shanghai, 21 
China). 22 
 23 
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 7 
HSV-2 gJ shRNA and control shRNA were purchased from GENEWIZ. Lentiviral vector 1 
pLL3.7 was constructed to expresses gJ shRNA or control shRNA under the mouse U6 2 
promoter. A CMV-EGFP reporter cassette was included in the vector to monitor 3 
expression. 4 
 5 
Cell lines and viruses 6 
African green monkey kidney cell line Vero, human cervical epithelial cell line HeLa and 7 
embryonic kidney cell line 293T were grown in Dulbecco’s modified Eagle’s medium 8 
(DMEM, Gibco) containing 10 % fetal bovine serum (FBS), 100 Units/ml penicillin and 9 
100 Units/ml streptomycin at 37 °C in 5 % CO2. Human retinal pigment epithelial cell 10 
line ARPE-19 was grown in DMEM/F-12 medium (50:50) supplemented with 10 % FBS, 11 
100 Units/ml penicillin and 100 Units/ml streptomycin at 37 °C in 5 % CO2. Human 12 
neuroblastoma cell line SH-SY5Y was grown in MEM supplemented with 10 % FBS, 13 
100 Units/ml penicillin and 100 Units/ml streptomycin at 37 °C in 5 % CO2. For the 14 
differentiation of SH-SY5Y cells, retinoic acid (RA, Sigma-Aldrich) was added at a final 15 
concentration of 10 μM in MEM supplemented with 10% FBS and maintained for 3 days. 16 
 17 
The VgJ2, HgJ2, AgJ2 and SHgJ2 cell lines were generated by transfection of Vero, HeLa, 18 
ARPE-19 and SH-SY5Y cells, respectively, with a plasmid expressing flag-tagged HSV-2 19 
gJ under the control of the viral thymidine kinase promoter. Transformed cells were 20 
selected for the ability to grow in the presence of geneticin and the expression of gJ-flag. 21 
The transfected cell lines were validated periodically to ensure the maintenance of gJ. 22 
VgJ2 and HgJ2 cells were passaged in DMEM supplemented with 10% FBS and 1 mg/ml 23 
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 8 
geneticin. AgJ2 cells were passaged in DMEM/F-12 medium (50:50) supplemented with 1 
10% FBS and 500 ug/ml geneticin. SHgJ2 cells were passaged in MEM supplemented 2 
with 10% FBS and 500 ug/ml geneticin. 3 
 4 
HSV-2 (strain G) was obtained from LGC standards. WT HSV-2-GFP carrying the 5 
complete genome of HSV-2 and green fluorescent protein (GFP) was kindly provided by 6 
Dr. Yasushi Kawaguchi, University of Tokyo, Japan, and served as the parental strain for 7 
construction of the gJ deleted virus. All viruses were grown and titered on Vero cells. 8 
Virus stock was stored at −80 °C before used for infection. The JEV strain SA14-14 was 9 
propagated in BHK-21 cells with DMEM containing 2% FBS. Virus titer was determined 10 
by a plaque assay on BHK-21 cells. 11 
 12 
Isolation of human primary epithelial cells 13 
Human foreskin tissues were obtained from Wuhan Children’s Hospital (Wuhan Maternal 14 
and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science 15 
& Technology. Firstly, tissues were washed twice with PBS. The unusable tissues were 16 
dissected off and the remaining tissues were minced into 3 to 4 mm pieces with a sterile 17 
scissors. Thereafter, the tissue pieces were digested with Dispase for 10-12 h at 4°C and 18 
Dispase was removed. The container with the tissue pieces was placed on ice. After the 19 
discard of any remaining supernatant, 0.25% trypsin (1 ml of trypsin for every 100 mg of 20 
tissue) was added followed by incubation at 4°C for 6 to 8 h to maximize penetration of 21 
the enzyme. The tissue pieces with residual trypsin were shifted to 37°C and slightly 22 
shaked for 20 min. Warm complete medium was subsequently added to the tissue pieces 23 
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 9 
and gently dispersed by pipetting. The separated cells were filtered through a stainless 1 
steel strainer (0.5-1.0 mm) and cultured in complete medium for 3 h. Human primary 2 
epithelial cells were cultured in 12-well plates to 90-95% confluence before use. 3 
 4 
Construction of gJ-null HSV-2  5 
The Escherichia coli strain harboring the full-length HSV-2 BAC with GFP tag was the 6 
parental strain for the mutant virus gJ-null HSV-2 (named DelgJ HSV-2-GFP) was grown 7 
at 32°C in LB with 25μg/ml chloramphenicol. DelgJ HSV-2-GFP mutant was constructed 8 
via homologous recombination as previously described (Zhang et al., 2015). Briefly, 9 
Gel-purified PCR product was obtained using Kanamycin (Kan) primers with 50bp 10 
extension homologous to the gJ sequence. Thereafter, 5μg of PCR products was 11 
electroporated into 50μl competent DY380 cells containing HSV-2 BAC with GFP tag, 12 
with the settings of 1.8 kv (0.1cm cuvettes), 25μF, and 200Ω. Single colony were isolated 13 
and cultured to produce DelgJ HSV-2-GFP BAC plasmid. The DelgJ HSV-2-GFP mutant 14 
was confirmed by PCR detection and verified by DNA sequencing (Sangon Biotech, 15 
China). WT HSV-2-GFP and DelgJ HSV-2-GFP BAC plasmids were transfected into 16 
Vero cells to produce WT (WT HSV-2-GFP) and mutant viruses (DelgJ HSV-2-GFP), 17 
respectively. VgJ2 cells were infected with DelgJ HSV-2-GFP to produce the pseudovirus 18 
RgJ HSV-2-GFP. The existence of gJ in RgJ HSV-2-GFP virions was confirmed by 19 
Western blot (Fig S3). 20 
 21 
Electron microscopy 22 
Vero cells were infected with DelgJ HSV-2-GFP or WT HSV-2-GFP at an MOI of 5. At 23 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
24 hpi, cells were harvested and fixed with 2.5% glutaraldehyde/1% paraformaldehyde in 1 
cacodylate buffer (0.1M sodium cacodylate [pH 7.4], 35mM sucrose, 4mM CaCl2), 2 
followed by staining in 1% OsO4 and 4% uranyl acetate for 2 h and dehydrating in a 3 
graded ethanol series (50%–100%), and subsequently embedded in epoxy resin 4 
Embed-812 (Electron Microscopy Sciences). Thin sections (80 nm) were stained with 2% 5 
saturated uranyl acetate for 15 min, rinsed with water, and then stained with Reynolds’ 6 
lead citrate for 15 min. Electron micrographs were taken on a Tecnai transmission 7 
electron microscope (FEI Tecnai G
2
 20 TWIN) at an accelerating voltage of 200 kV. 8 
 9 
One-step growth curve  10 
One-step growth curve was measured following infection of preformed Vero, HeLa, or 11 
ARPE-19 monolayers with HSV-2 at an MOI of 10 PFU/cell. Adsorption was allowed to 12 
proceed for 2 h at 37 °C before the inoculum was removed and residual inoculum was 13 
neutralized by incubation for 15 min with medium containing the HSV-2 pAb (1:100 14 
dilution). The Vero, HeLa, or ARPE-19 monolayers were then washed twice with fresh 15 
medium and incubated for 0, 6, 12, 18 and 24 hours post infection (hpi) before being 16 
harvested and assayed for virus yields. 17 
 18 
Infectious center assay 19 
Infectious center assay was carried out as previously described (Jenssen et al., 2008). In 20 
brief, Vero or HeLa cells plated in 6-well plates at 50% confluence were exposed to DelgJ 21 
HSV-2-GFP or WT HSV-2-GFP at an MOI of 5 PFU/cell at 37°C. In parallel, VgJ2 or 22 
HgJ2 cells were infected with RgJ HSV-2-GFP. After 2 h of incubation, cells were 23 
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 11 
washed once with PBS and then treated with proteinase K for 45 min to remove adsorbed 1 
but not internalized viruses. Proteinase K was then inactivated with 2 mM PMSF in PBS 2 
containing 3% bovine seroalbumin (BSA). The monolayer was then washed twice with 3 
PBS and cultured in growth medium supplemented with an anti-HSV-2 antibody 4 
(PAB13979, Abnova) at a dilution of 1:1000 to neutralize the extracellular HSV-2. After a 5 
total incubation of 5.5 h, the infected cells were detached with trypsin-EDTA, 6 
resuspended in growth medium, and ~80 cells were plated onto 50% confluent 7 
monolayers of uninfected Vero, HeLa, VgJ2 or HgJ2 cells. Cells were maintained in 8 
growth medium containing anti-HSV-2 polyclonal antibody. 2 days later, cells were fixed 9 
and nuclei were dyed by Hoechst 33342 (Beyotime). Stained cells were analyzed using 10 
confocal microscopy (NIKON). Plaques and syncytia formation were photographed and 11 
the plaque areas were compared.  12 
 13 
Flow cytometry 14 
For cell-to-cell spread assay, HeLa or ARPE-19 cells were infected with the same amount 15 
of DelgJ HSV-2-GFP and WT HSV-2-GFP, respectively, at an MOI of 10 for 2h. In 16 
parallel, HgJ2 or AgJ2 cells were infected with RgJ HSV-2-GFP. After digestion by 17 
trypsin, 100 cells per samples were taken out followed by co-cultivation with HeLa, 18 
ARPE-19, HgJ2, AgJ2, SHgJ2 or SH-SY5Y cells which were labeled with CellTracker 19 
Blue fluorescence dye. 2 days later, cells were washed three times with flow cytometry 20 
buffer and fixed with 1% paraformaldehyde. The CellTracker Blue
+
 GFP
+
 populations 21 
were analyzed using FACS Calibur flow cytometer (BD). Data were analyzed by Flowjo 22 
software. 23 
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 1 
Viral adsorption and entry assay  2 
HeLa or ARPE-19 cells (~8×10
5
 per well) were plated onto 6-well plates overnight. To 3 
assess the adsorption of DelgJ HSV-2-GFP or WT HSV-2-GFP, the cultures were 4 
subsequently replaced with cold (4°C) medium and placed on ice for 10 min, followed by 5 
the addition of precooled DelgJ HSV-2-GFP or WT HSV-2-GFP (MOI=5 PFU/cell) and 6 
an incubation at 4°C for 60 min. After removal of viruses, cells were washed three times 7 
with cold PBS and harvested. The HSV-2 genomic DNA was exacted using QIAamp 8 
DNA Blood Mini Kit (51104, Qiagen) and then detected by quantitative PCR. To assess 9 
the entry of DelgJ HSV-2-GFP or WT HSV-2-GFP, the cultures were subsequently 10 
infected with DelgJ HSV-2-GFP or WT HSV-2-GFP (MOI=5 PFU/cell) and incubated at 11 
37°C for 2h. After removal of viruses, the monolayers were treated with proteinase K for 12 
45 min to remove adsorbed but not internalized viruses. Proteinase K was then 13 
inactivated with 2 mM PMSF in PBS containing 3% BSA followed by two washes with 14 
PBS. Cells were harvested and the HSV-2 genomic DNA was extracted using QIAamp 15 
DNA Blood Mini Kit (51104, Qiagen). The copies of HSV-2 genomic DNA were 16 
detected by quantitative PCR. 17 
 18 
Quantitative PCR 19 
HeLa, ARPE-19 or SH-SY5Y cells were infected with DelgJ-HSV-2-GFP or 20 
WT-HSV-2-GFP at an MOI of 5 PFU/cell or mock infected. In parallel, HgJ2, AgJ2 or 21 
SHgJ2 cells were infected with RgJ HSV-2-GFP. At 48 hpi, cells were collected and the 22 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 13 
viral genomic DNA was extracted using QIAamp DNA Blood Mini Kit (51104, Qiagen). 1 
The genomic DNAs obtained from HeLa, ARPE-19 or SH-SY5Y cells infected with 2 
DelgJ-HSV-2-GFP or WT-HSV-2-GFP or mock infected, or from HgJ2, AgJ2 or SHgJ2 3 
cells infected with RgJ HSV-2-GFP were used as the templates for the amplification of a 4 
highly specific nucleotide region of ICP0 gene (RL2). Primers 5′- 5 
GTGCATGAAGACCTGGATTCC -3′ and 5′- GGTCACGCCCACTATCAGGTA -3′ 6 
were used for ICP0 amplification (Cheshenko et al., 2010). GAPDH was used as an 7 
internal control amplified with primers 5’-GGGAAGCTCACTGGCATGG-3’ and 8 
5’-TTACTCCTTGGAGGCCATGT-3’. Relative quantitative PCR was performed using a 9 
SYBR Green Real-Time PCR Master Mix (Toyobo) Dye and an ABI StepOne real-time 10 
PCR system (Applied Biosystems). The final reaction conditions were as follow: 95°C 11 
for 1 min, followed by 40 cycles of 95°C for 15 sec, 60°C for 15 sec, and 72°C for 45 12 
sec. The difference in gene expression was calculated on the basis of 2
-ΔΔCT 
values. 13 
 14 
Production and quantitation of HIV-1 15 
293T cells were transfected with plasmid pNL4-3 and pgJ-flag, pgL-flag or pcDNA3.1 16 
using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions to 17 
produce HIV-1. At 48h post transfection, supernatants and cells were harvested separately. 18 
The expression level of p24 in supernatants or cell lysates was measured by p24 ELISA. 19 
The titer of infectious HIV-1 in supernatants was analyzed in an infection assay using 20 
supernatants containing HIV-1 to infect TZM-bl cells. 21 
 22 
Western Blot 23 
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 14 
Prepared cell lysates or immunoprecipitates were resolved by 10% or 12% SDS-PAGE 1 
and transferred to 0.45 µm polyvinylidene difluoride membranes (Millipore). Nonspecific 2 
binding was blocked using 5% non-fat milk in PBS overnight at 4°C. The membrane was 3 
incubated with primary antibody against gB at a dilution of 1:2000, gD at a dilution of 4 
1:1000, FLAG at a dilution of 1:3000, GFP at a dilution of 1:1000 and β-actin at a 5 
dilution of 1:500, for 1 h at 37°C. The membrane was washed five times with 0.1% 6 
Tween 20/PBS, followed by incubation for 1 h with HRP conjugated goat anti–rabbit 7 
secondary antibody (1:10,000, BA1054, Boster) or HRP conjugated goat anti–mouse 8 
secondary antibody (1:10,000, BA1050, Boster). After five washes with 0.1% 9 
Tween-20/PBS, the bands were visualized by exposure to FluorChem HD2 Imaging 10 
System (Alpha Innotech) after the addition of chemiluminescent substrate (SuperSignal® 11 
West Dura Extended Duration Substrate, 34075, Thermo Scientific Pierce). 12 
 13 
Statistical analysis 14 
All experiments were repeated for at least three times. Data are presented as mean  15 
standard deviation (SD) unless otherwise specified. All statistical analysis was performed 16 
by GraphPad Prism. The difference of mean value was analyzed by a paired Student’s 17 
t-test. P < 0.05 was considered statistically significant. 18 
19 
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 15 
Results  1 
Virus production is impaired in cells infected with gJ-null HSV-2  2 
To investigate the function of HSV-2 gJ during viral infection, Bacterial artificial 3 
chromosome (BAC) plasmid containing the gJ deleted HSV-2 genome with GFP tag was 4 
constructed. The BAC DNA plasmids were transfected into Vero cells to produce gJ-null 5 
HSV-2 (named DelgJ HSV-2-GFP) and wild-type HSV-2 (WT HSV-2-GFP), respectively. 6 
The ORFs of gJ and Kanamycin (Kan) in DelgJ HSV-2-GFP and WT HSV-2-GFP were 7 
confirmed by PCR (Fig. S1 A). The fluorescence of GFP was detected in Vero cells 8 
infected with the four DelgJ HSV-2-GFP clones or WT HSV-2-GFP (Fig. S1 B). Electron 9 
microscopy also demonstrated the production of virions in Vero cells infected with the 10 
four DelgJ HSV-2-GFP clones and WT HSV-2-GFP, respectively (Fig. S1 C). Since US4 11 
(coding gG) locates in the upstream of US5 (coding gJ), and US5 and US6 (coding gD) 12 
form a transcribed gene cluster (Dolan et al., 1998), Western blot analysis was conducted 13 
to confirm that gJ ORF deletion did not affect the expression of its adjacent gene (US4 14 
and US6) (Fig. S1 D). These results indicated that the constructed gJ deleted HSV-2 was 15 
successfully produced in Vero cells. The four DelgJ HSV-2-GFP clones and WT 16 
HSV-2-GFP were used to infect Vero cells at an MOI of 5 PFU/cell. The supernatants and 17 
cells were collected to measure virus yields by plaque assay at 24 hpi. As shown in Fig. 18 
S2, the viral yields of the four DelgJ HSV-2-GFP clones were ~2 fold less than that of 19 
WT HSV-2-GFP. Given that the four DelgJ HSV-2-GFP clones had a similar impact on 20 
virus production, the 4# DelgJ HSV-2-GFP was used for subsequent experiments.  21 
 22 
The rates of adsorption and entry of DelgJ HSV-2-GFP and WT HSV-2-GFP were 23 
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 16 
compared in HeLa and ARPE-19 cell monolayers. To assess the adsorption, the HeLa and 1 
ARPE-19 cultures were subsequently replaced with cold (4°C) medium and placed on ice 2 
for 10 min, followed by the addition of precooled DelgJ HSV-2-GFP or WT HSV-2-GFP 3 
(MOI=5 PFU/cell) and an incubation at 4°C for 60 min. After removal of viruses, 4 
infected cells were collected and the viral genomic DNA were extracted and analyzed by 5 
monitoring the HSV-2 IE protein ICP0 using relative quantitative PCR. As shown in Fig. 6 
1A, the mean fold change of ICP0 was around one, indicating that there was no 7 
difference in adsorption between DelgJ HSV-2-GFP and WT HSV-2-GFP. To assess the 8 
entry, the HeLa and ARPE-19 cultures were subsequently infected with DelgJ 9 
HSV-2-GFP or WT HSV-2-GFP (MOI=5 PFU/cell) and incubated at 37°C for 2h. After 10 
removal of viruses, the monolayers were treated with proteinase K to remove adsorbed 11 
but not internalized viruses. Cells were subsequently harvested and the HSV-2 genomic 12 
DNA was extracted. The copies of HSV-2 genomic DNA were compared by relative 13 
quantitative PCR. The entry rates of mutant and wild-type HSV-2 were also similar (Fig. 14 
1B). The virus production was subsequently examined. DelgJ HSV-2-GFP and WT 15 
HSV-2-GFP were used to infect Vero, ARPE-19, HeLa, and SH-SY5Y cells at an MOI of 16 
5 PFU/cell. At 24 hpi, the supernatants and cells were collected and the virus yields were 17 
measured by plaque assay. As shown in Fig. 1C, the viral yield of DelgJ HSV-2-GFP was 18 
2-3 fold less than that of WT HSV-2-GFP in the four different types of cell lines. The 19 
paralleled infected cells were collected and the viral genomic DNA was analyzed by 20 
monitoring the HSV-2 IE protein ICP0 with relative quantitative PCR. The mean fold 21 
change of ICP0 in DelgJ HSV-2-GFP-infected cells was similar to that in WT 22 
HSV-2-GFP-infected cells, indicating that the virus production of DelgJ HSV-2-GFP was 23 
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 17 
much less than that of WT HSV-2-GFP (Fig. 1D). Following harvest of cell lysates at 24 1 
hpi, the expression level of viral protein gD in DelgJ HSV-2-GFP or WT HSV-2-GFP 2 
infected cells were determined by western blot. As shown in Fig. 1E, the expression level 3 
of gD in WT HSV-2-GFP infected cells was higher than that from DelgJ HSV-2-GFP 4 
infected cells.  5 
 6 
We also examined the virus production of WT HSV-2 and DelgJ HSV-2 in human 7 
primary epithelial cells isolated from human foreskin tissues. The results of primary 8 
epithelial cells isolated from 5 donors were similar to those from the epithelial cell lines 9 
(Fig. 1F). One-step growth curve was measured following infection of preformed Vero 10 
monolayers. Although similar growth curves were achieved, the virus production of 11 
DelgJ HSV-2-GFP was ~2 fold less than that of WT HSV-2-GFP at 18 and 24hpi (Fig. 2). 12 
These data together demonstrated that HSV-2 gJ is beneficial for virus production. 13 
 14 
Knockdown of gJ by shRNA decreases HSV-2 replication 15 
The above results were obtained from the constructed recombinant viruses DelgJ 16 
HSV-2-GFP and WT HSV-2-GFP containing GFP in their genomes. To further confirm 17 
these findings, we assessed the replication of wild-type HSV-2 strain G by shRNA 18 
knockdown of gJ. Serial concentration gradients of retroviral vectors expressing gJ 19 
shRNA or control shRNA were generated and transfected into HeLa cells pre-transfected 20 
with pgJ-flag or pcDNA3.1. Western blot showed that, at 48 hours post transfection, all of 21 
the three gJ shRNAs reduced the expression of gJ with different efficiency with the #1 gJ 22 
shRNA (Fig. 3A) being the most effective one, and the #1 gJ shRNA was therefore used 23 
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 18 
in the following experiments. HeLa and ARPE-19 cells were transfected with retroviral 1 
vectors expressing #1 gJ shRNA or control shRNA followed by infection with HSV-2 2 
strain G at an MOI of 5 PFU/cell. Supernatants and cells were collected at 24 hpi, and 3 
thereafter, the viral yield of samples was analyzed using plaque assays. As shown in Fig. 4 
3B, the virus production of HSV-2 decreased 2-3 fold in both HeLa and ARPE-19 cells 5 
treated with gJ shRNA, confirming that gJ is indeed important for HSV-2 production. 6 
 7 
Ectopic expression of gJ enhances the replication of both wild-type and gJ-null 8 
HSV-2 9 
Having demonstrated that both gJ knockout and knockdown resulted in decreased HSV-2 10 
production, we next asked whether ectopic expression of gJ has an impact on HSV-2 11 
replication. For this purpose, HeLa and ARPE-19 cells were transfected with pgJ-flag or 12 
pcDNA3.1 followed by infection with WT HSV-2-GFP or DelgJ HSV-2-GFP at an MOI 13 
of 5 PFU/cell. Supernatants and cells were collected at 24 hpi, and thereafter, the viral 14 
yield was analyzed by plaque assays. As shown in Fig. 4A and C, the virus production of 15 
both WT HSV-2-GFP and DelgJ HSV-2-GFP was increased in the gJ-expressing cells. 16 
The expression of HSV-2 protein gD in the parallel samples was also measured by 17 
Western blot, showing that the expression level of gD in WT HSV-2-GFP infected cells 18 
was higher than that in DelgJ HSV-2-GFP infected cells (Fig. 4B and D). Taken together, 19 
these results suggested that gJ appears not to be essential for HSV-2 replication and 20 
transmission and instead may function as a regulatory protein to increase virus 21 
production. 22 
 23 
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Knockout of HSV-2 gJ significantly impaired plaque and syncytia formation and 1 
decreased virus production 2 
We observed that all the cells infected with DelgJ HSV-2-GFP or WT HSV-2-GFP turned 3 
round and there was no obvious difference between the pathological cells (data not shown) 4 
infected with a high MOI of the viruses (great than or equal to 5). On the contrary, most 5 
of the pathological cells infected with WT-HSV-2-GFP were larger than those infected 6 
with DelgJ HSV-2-GFP when Vero cells were infected at a lower MOI (~0.1) (Fig. S1B). 7 
It seemed that the syncytia formation decreased in cells infected with the DelgJ 8 
HSV-2-GFP. We further investigated the impact of HSV-2 gJ on plaque and syncytia 9 
formation using a Vero cell line stably expressing gJ-flag (VgJ2). VgJ2 cells were 10 
infected with DelgJ HSV-2-GFP at an MOI of 1 PFU/cell to produce the pseudovirus RgJ 11 
HSV-2-GFP. At 24hpi, pseudoviruses were harvested and concentrated through 12 
ultracentrifugation. Following Western blot, the expression of gB and gJ-flag was 13 
confirmed in the lysates containing DelgJ HSV-2-GFP or RgJ HSV-2-GFP (Fig. S3). To 14 
achieve a better observation, DelgJ HSV-2-GFP and WT HSV-2-GFP were used to infect 15 
Vero and HeLa cells at an extremely low MOI (~80 PFU/1×10
6
 cells), respectively. After 16 
removal of the inoculum, cells were maintained in growth medium containing an 17 
anti-HSV-2 antibody (Abnova) to neutralize extracellular HSV-2. Plaques and syncytia 18 
formation were photographed and the plaque areas were compared after 48 h incubation 19 
at 37°C. In parallel, we examined the plaque formation of RgJ HSV-2-GFP in VgJ2 cells. 20 
As shown in Fig. 5A and B, DelgJ HSV-2-GFP produced significantly smaller plaques on 21 
Vero monolayers than did WT HSV-2-GFP, but produced full-size plaques on VgJ2 cells. 22 
A HeLa cell line stably expressing gJ-flag (HgJ2) was also examined. Fluorescence 23 
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 20 
microscopy analysis of plaque and syncytia formation also showed that, compared with 1 
those of WT HSV-2-GFP, plaques were smaller and syncytia formation was significantly 2 
inhibited in Vero and HeLa cells infected with DelgJ HSV-2-GFP, whereas full-size 3 
plaques were observed on VgJ2 or HgJ2 cells infected with RgJ HSV-2-GFP (Fig. 5C). 4 
Meanwhile, an ARPE-19 cell line stably expressing gJ-flag (AgJ2) was also tested. HeLa 5 
or ARPE-19 cells were infected with DelgJ HSV-2-GFP or WT HSV-2-GFP at a very low 6 
MOI (~80 PFU/1×10
6
 cells). In parallel, HgJ2 or AgJ2 cells were infected with RgJ 7 
HSV-2-GFP. After 48 h incubation at 37°C, cells were harvested and analyzed by flow 8 
cytometry. As shown in Fig. 6A, in both HeLa and ARPE-19 cells, the proportion of 9 
GFP
+
 cells infected with DelgJ HSV-2-GFP was less than that with WT HSV-2-GFP, 10 
while the proportion of GFP
+
 cells infected with RgJ DelgJ HSV-2 was similar to that 11 
with WT HSV-2-GFP, suggesting that cell-to-cell spread of DelgJ HSV-2-GFP was 12 
indeed slower than that of WT HSV-2-GFP in monolayers, though gJ did not impact the 13 
absorption and entry of virus particles (Fig. 1A and 1B).  14 
 15 
To determine whether gJ influences the neuron-to-neuron transmission of HSV-2, the 16 
differentiated neuron-like cells SH-SY5Y were infected with DelgJ HSV-2-GFP or WT 17 
HSV-2-GFP at a very low MOI (~80 PFU/1×10
6
 cells) followed by analysis with flow 18 
cytometry. A SH-SY5Y cell line stably expressing gJ-flag (SHgJ2) was also examined. In 19 
parallel, SHgJ2 cells were infected with RgJ HSV-2-GFP. As shown in Fig 6A, the results 20 
obtained from SH-SY5Y cells were in accordance with those from epithelia cells HeLa 21 
and ARPE-19 (Fig. 6A). In parallel, the levels of viral genomic DNA and virus 22 
production were also examined. Relative quantitative PCR and plaque assay showed that 23 
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 21 
the viral genomic DNA and the viral yield in cells infected with DelgJ HSV-2-GFP were 1 
less than those with WT HSV-2-GFP or RgJ HSV-2-GFP (Fig. 6B and C). These results 2 
indicated that knockout of gJ significantly impacted HSV-2 cell-to-cell spread and 3 
contributed to the decreased virus production. 4 
 5 
gJ promotes cell-to-cell spread of HSV-2 among epithelial cells or from epithelial 6 
cells to neuronal cells  7 
HSV-2 spread is predominantly dependent on cell-to-cell contact rather than on particle 8 
release and reentry (RC., 2001). The inhibition of virus plaque and syncytia formation in 9 
DelgJ-HSV-2-GFP infected cell monolayers indicated that gJ is important for an efficient 10 
cell-to-cell spread of the virus. To elucidate whether gJ-promoted cell-to-cell spread is 11 
cell type specific, we conducted experiments to determine the ratio of HSV-2 being 12 
transferred from infected to uninfected cells. Firstly, HeLa or ARPE-19 cells were 13 
infected with the same amount of DelgJ HSV-2-GFP or WT HSV-2-GFP at an MOI of 10 14 
for 2h. In parallel, HgJ2 or AgJ2 cells were infected with RgJ HSV-2-GFP. Following 15 
digestion by trypsin, 100 cells per samples were co-cultivated with corresponding HeLa, 16 
ARPE-19, HgJ2 or AgJ2 cells labeled with CellTracker Blue fluorescence dye for 2 days. 17 
HSV-2 transmission from infected to uninfected cells was subsequently quantified by 18 
analyzing CellTracker Blue
+
 GFP
+
 populations with flow cytometry. As shown in Fig. 7B 19 
and E, the proportion of CellTracker Blue
+
 GFP
+
 HeLa or ARPE-19 cells in sample 20 
containing DelgJ-HSV-2-GFP was 0.199  0.041% and 0.201  0.044% respectively, 21 
while the proportion of CellTracker Blue
+
 GFP
+
 HeLa or ARPE-19 cells in sample 22 
containing WT HSV-2-GFP was 0.680  0.096% and 0.857  0.051%, respectively. As 23 
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 22 
expected, the proportion of CellTracker Blue
+
 GFP
+
 cells increased to 0.654  0.094% 1 
and 0.846  0.053% in HgJ2 and AgJ2, respectively. Virus production of the parallel 2 
samples was also detected by plaque assay. The viral yield from DelgJ HSV-2-GFP 3 
infected cells was less than that from WT HSV-2-GFP infected cells or RgJ HSV-2-GFP 4 
(Fig. 7C and F). These results together informed that cell-to-cell spread of HSV-2 5 
promoted by gJ from HeLa to HeLa cells was similar to that from ARPE-19 to ARPE-19 6 
cells, indicating that gJ can promote HSV-2 cell-to-cell spread among epithelial cells.  7 
 8 
In addition to mucosal epithelial cells, it has been documented that HSV-1/HSV-2 can 9 
infect sensory neurons following primary infections of mucosal and submucosal tissues 10 
(Cook and Stevens, 1973; Kristensson et al., 1971). To determine whether gJ plays a role 11 
in HSV-2 epithelial cell-to-neuronal cell transmission, epithelial cells ARPE-19 and the 12 
differentiated neuron-like cells SH-SY5Y were used for subsequent experiments. 13 
ARPE-19 cells were infected with the same amount of DelgJ HSV-2-GFP or WT 14 
HSV-2-GFP at an MOI of 10 for 2h, followed by digestion with trypsin. In parallel, AgJ2 15 
cells were infected with RgJ HSV-2-GFP. 100 cells per samples were co-cultivated with 16 
uninfected SH-SY5Y or SHgJ2 cells labeled with CellTracker Blue fluorescence dye for 17 
2 days. The CellTracker Blue
+
 GFP
+
 populations were analyzed by flow cytometry, while 18 
the virus production of the parallel samples was detected by plaque assay. As shown in 19 
Fig. 7H, the proportion of CellTracker Blue
+
 GFP
+
 SH-SY5Y cells in sample containing 20 
DelgJ HSV-2-GFP was 0.154  0.053%, while the proportion of CellTracker Blue+ GFP+ 21 
ARPE-19 cells in samples containing WT HSV-2-GFP and RgJ HSV-2-GFP was 0.853  22 
0.109% and 0.891  0.096%, respectively, indicating that the proportion of newly 23 
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 23 
infected cells which co-cultured with DelgJ HSV-2-infected cells was fewer than that 1 
with WT or RgJ HSV-2-infected cells and that the cell-to-cell spread of DelgJ HSV-2 was 2 
slower than that of WT or RgJ HSV-2. In agreement, the viral yield of samples containing 3 
DelgJ HSV-2-GFP was less than that of samples containing WT HSV-2-GFP or RgJ 4 
HSV-2-GFP (Fig. 7I). These data highlighted that HSV-2 gJ can promote cell-to-cell 5 
spread of the virus between different cell types, and of particular interest from epithelial 6 
cells to neuronal cells.  7 
 8 
HSV-2 gJ increases viral protein expression and virus production  9 
Given that the expression level of viral protein gD in cells infected with WT HSV-2-GFP 10 
was higher than that with DelgJ HSV-2-GFP, we conducted experiments to address 11 
whether gJ alone influence the expression level of other HSV-2 proteins. 293T cells were 12 
contransfected with pcDNA3.1, pgL-flag or pgJ-flag together with plasmids expressing 13 
immediate early proteins ICP0, ICP22 or ICP27. Western blot showed that the expression 14 
level of the viral immediate early proteins in cells cotransfected with gJ-flag plasmid was 15 
substantially higher than that with pcDNA3.1 or pgL-flag (Fig. 8A left). We also assessed 16 
the expression level of the late protein gB, which is crucial for cell-to-cell spread of the 17 
virus. 293T cells were contransfected with pcDNA3.1, pgL-flag or pgJ-flag together with 18 
plasmid expressing gB. Western blot showed that the expression level of gB increased in 19 
gJ-flag transfected cells (Fig. 8A right). The correlation between the dose of gJ and the 20 
expression level of ICP27 was further examined. As shown in Fig. 8B, the increase of 21 
gJ-flag dose positively correlated with a higher expression level of ICP27. A positive 22 
association between the expression of gJ and other HSV-2 viral proteins indicated that gJ 23 
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 24 
can increase the expression of HSV-2 viral proteins.  1 
 2 
It was previously reported that HSV-1 ICP0 and ICP4 stimulated HIV-1 replication when 3 
cotransfected with an infectious HIV-1 clone (Ostrove et al., 1987). In addition, US11 4 
protein was also shown to increase HIV-1 expression (Diaz et al., 1996). We asked 5 
whether gJ can increase viral protein expression and virus yield of other viruses. 293T 6 
cells were cotransfected with pcDNA3.1, pgL-flag or pgJ-flag together with an infectious 7 
HIV-1 clone (pNL4-3). At 48h post transfection, supernatants and cells were harvested. 8 
The expression level of p24 in supernatants and cell lysates was measured by ELISA, 9 
while the production of infectious HIV-1 in supernatants was analyzed by using 10 
supernatants containing HIV-1 to infect TZM-bl cells. As shown in Fig. 8C, in both 11 
supernatants and cell lysates, the expression level of p24 in gJ-expressing cells was 12 
significantly higher than that in gL-flag or pcDNA3.1-transfected cells. Accordingly, the 13 
infectious HIV-1 produced from gJ-expressing cells was much more than that from 14 
gL-flag or pcDNA3.1-transfected cells (Fig. 8D). We also examined the effect of HSV-2 15 
gJ on a flavivirus JEV. 293T cells were contransfected with pcDNA3.1, pgL-falg or 16 
pgJ-flag together with the plasmid expressing JEV NS3. Western blot showed that the 17 
expression level of NS3 in gJ-expressing cells was higher than that in gL-flag or 18 
pcDNA3.1-transfected cells (Fig. 8E). To assess the influence of gJ on virus production, 19 
HeLa cells transfected with control pcDNA3.1 or plasmid expressing gJ-flag or gL-flag 20 
were infected with JEV at an MOI of 10 PFU/cell. At 24hpi, the viral yield was measured 21 
by plaque assay. Compared to that in pcDNA3.1-transfected cells, the production of JEV 22 
in gJ-expressing cells increased ~2.5-fold (Fig. 8F). Collectively, these results suggested 23 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 25 
that HSV-2 gJ can increase viral protein expression and virus production regardless of 1 
virus species. 2 
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Discussion 1 
The major mode of HSV-2 transmission is cell-to-cell spread, an efficient strategy for the 2 
virus to circumvent the host immune response. However, despite being a predominant 3 
mode of viral spread in vivo, cell-to-cell transmission has not been studied to the same 4 
extent as virus-to-cell transmission. In this study, we found that, in the context of viral 5 
infection, HSV-2 gJ promotes cell-to-cell spread and syncytia formation. Moreover, 6 
gJ-promoted cell-to-cell spread of HSV-2 was observed not only among HeLa or 7 
ARPE-19 cells, but also from ARPE-19 to differentiated SH-SY5Y cells, suggesting that 8 
gJ likely facilitates cell-to-cell spread of HSV-2 among epithelial cells as well as from 9 
epithelial cells to neuronal cells. It is a hazardous voyage from the primary infection sites 10 
to the latent infection sites in vivo for the virus. To date, there has been no evidence that 11 
HSV-2 uses antigenic variation to escape host control, implying that the virus likely uses 12 
alternative strategies such as cell-to-cell spread in order to be successfully transmitted. 13 
Our findings that gJ facilitates cell-to-cell spread of the virus among epithelial cells and 14 
from epithelial cells to neuronal cells may have important implications when considering 15 
HSV-2 mucosal transmission as well as its dissemination cross different tissues in vivo.  16 
 17 
To investigate the function of HSV-2 gJ during viral infection, we constructed a gJ-null 18 
HSV-2 (named DelgJ HSV-2-GFP) and made pseudovirus RgJ HSV-2-GFP using our 19 
constructed stable cell lines expressing gJ. The results demonstrated that the viral yields, 20 
plaque and syncytia formation were rescued on cell lines stably expressing gJ, suggesting 21 
that the non-essential protein, HSV-2 gJ, is likely to be beneficial for cell-to-cell spread 22 
and virus production. The difference of viral yields between gJ-null HSV-2 (DelgJ 23 
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HSV-2-GFP) and WT HSV-2 was relatively small (~2-3 fold) but statistically significant, 1 
suggesting that HSV-2 gJ is likely to be beneficial for virus production, although the 2 
biological significance remains to be addressed in future animal study. 3 
 4 
Our gJ knockout and knockdown experiments together demonstrated that HSV-2 gJ is 5 
beneficial for viral protein expression and virus production, which consequently promotes 6 
HSV-2 cell-to-cell spread and syncytia formation. Major participants in the immune 7 
escape process include HSV-1/HSV-2 envelop proteins which were reported to be 8 
involved in cell-to-cell spread such as gB (Cheshenko and Herold, 2002) or membrane 9 
fusion (Lin et al., 2011). We demonstrated that gJ increases the expression levels of other 10 
HSV-2 proteins. Although beyond the scope of this current study, it will be interesting to 11 
address the precise mechanism by which HSV-2 gJ influences viral protein expression 12 
and virus production. It is probable that the expression level of proteins involved in 13 
cell-to-cell spread or membrane fusion is likely to be enhanced which further promotes 14 
cell-to-cell spread and syncytia formation. Since HSV-2 gJ increases the expression level 15 
of viral proteins and virus production, we hypothesized that gJ might also increase viral 16 
protein expression and virus yields of other virus species. Indeed, gJ not only enhanced 17 
the expression level of viral proteins including HIV-1 p24 and JEV NS3, but also 18 
increased the production of the tested viruses HIV-1 and JEV. Although we cannot rule 19 
out other possible mechanisms, our findings provide evidence that HSV-2 gJ likely 20 
functions as a regulator of viral protein expression and virus production. 21 
 22 
It was thought that HSV-1 gJ is a nonessential glycoprotein dispensable for virus 23 
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replication in cultured cells as disruption of the US5 gene did not significantly alter 1 
HSV-1 virus virulence (Baines and Roizman, 1991; Balan et al., 1994). Nevertheless, 2 
several studies later reported that HSV-1 gJ plays roles in inhibiting apoptosis (22-25) 3 
and in inducing the formation of reactive oxygen species (26). In the current study, we 4 
have revealed a novel role of HSV-2 gJ, showing that gJ promotes cell-to-cell spread and 5 
syncytia formation, and likely functions as a regulator of viral protein expression and 6 
virus production. HSV-1 gJ was previously reported to inhibit apoptosis and has no 7 
impact on cell-to-cell spread (Baines and Roizman, 1991; Balan et al., 1994). The 8 
different roles played by HSV-2 and HSV-1 gJs in cell-to-cell spread may reflect the 9 
primary transmission modes of these two viruses. HSV-2 transmission is mainly through 10 
cell-to-cell contact whereas the major mode of HSV-1 transmission is via virus-to-cell 11 
infection.  12 
 13 
Conclusions 14 
In conclusion, we have demonstrate that HSV-2 gJ promotes HSV-2 cell-to-cell spread 15 
and syncytia formation, and further showed that gJ can increase viral protein expression 16 
and virus production.  17 
18 
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Figure legends 
Fig. 1.  Knockout of gJ results in impaired HSV-2 production in different cell 
types. The BAC DNA was transfected into Vero cells to produce gJ-null HSV-2 
(named DelgJ HSV-2-GFP) and wild-type HSV-2 (WT HSV-2-GFP). (A) The 
adsorption of DelgJ HSV-2-GFP and WT HSV-2-GFP were compared using relative 
quantitative PCR. HeLa cells were infected with DelgJ HSV-2-GFP or WT 
HSV-2-GFP for 1h at 4°C. (B) The entry of DelgJ HSV-2-GFP and WT HSV-2-GFP 
were compared on cell monolayers for 2h at 37°C. The viral genomic DNA in (A) and 
(B) were extracted and analyzed by monitoring HSV-2 IE protein ICP0 using relative 
quantitative PCR. The difference in ICP0 gene was calculated on the basis of 2
-ΔΔCT
 
values.  (C) The viral yields of DelgJ HSV-2-GFP and WT HSV-2-GFP in different 
cell lines. Vero, ARPE-19, HeLa or SH-SY5Y cells were infected with DelgJ 
HSV-2-GFP or WT HSV-2-GFP at an MOI of 5 PFU/cell. The supernatants and cells 
were collected at 24 hours post infection (hpi) and the virus yields were measured by 
plaque assay. (D) The viral genomic DNA in the parallel samples of (C) were 
extracted and analyzed by monitoring HSV-2 IE protein ICP0 using relative 
quantitative PCR. The difference in ICP0 gene was calculated on the basis of 2
-ΔΔCT
 
values. (E) The expression level of gD in the parallel samples of (C) was determined 
by western blot where actin was used as a loading control. Molecular weight 
standards in kilodaltons are shown on the left. (F) The virus production of DelgJ 
HSV-2-GFP and WT HSV-2-GFP in human primary epithelial cells. Human primary 
epithelial cells isolated from human foreskin tissues were infected with DelgJ 
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HSV-2-GFP or WT HSV-2-GFP at an MOI of 5 PFU/cell. The supernatants and cells 
were collected at 24 hpi and the virus yields were measured by plaque assay. Data 
shown are mean  SD of three independent experiments with each condition 
performed in triplicate (A, B, C, D and F). One representative experiment out of three 
is shown (E). “ns” represents not significant, * represents P<0.05 and ** represents 
P<0.01, *** represents P<0.001. 
 
Fig. 2. One-step growth curves of DelgJ HSV-2-GFP and WT HSV-2-GFP. Vero 
(A), HeLa (B) and ARPE-19 (C) cells were infected with DelgJ-HSV-2GFP or 
WT-HSV-2GFP at an MOI of 5 PFU/cell. At 0, 6, 12, 18, 24, 30 and 36 hpi, cells and 
supernatants were harvested and the viral yields were tittered on Vero cells. Data 
shown are mean  SD of three independent experiments with each condition 
performed in triplicate. 
 
Fig. 3. shRNA knockdown of gJ results in decreased HSV-2 production. (A) The 
knockdown efficiency of gJ shRNA. Serial concentration gradients of retroviral 
vectors expressing gJ shRNA (1-4#) or control shRNA were used to treat HeLa cells 
transfected with pgJ-flag or pcDNA3.1. At 48 hours post transfection, the expression 
of gJ-flag was measured by western blot where actin was used as a loading control. 
GFP signal represents the transfection efficiency. Molecular weight standards in 
kilodaltons are shown on the left. One representative experiment out of three is shown. 
(B) HSV-2 production in the gJ shRNA or control shRNA treated cells. HeLa or 
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ARPE-19 cells transfected with retroviral vectors expressing #1 gJ shRNA or control 
shRNA followed by infection with HSV-2 strain G at an MOI of 5 PFU/cell. 
Supernatants and cells were collected at 24 hpi, and thereafter, the viral yield of 
samples was analyzed using plaque assays. Data shown are mean  SD of three 
independent experiments with each condition performed in triplicate. ** represents 
P<0.01. 
 
Fig. 4. Ectopic expression of gJ enhances the replication of both WT and gJ-null 
HSV-2. HeLa or ARPE-19 cells were transfected with pgJ-flag or pcDNA3.1 
followed by infection with WT HSV-2-GFP or DelgJ HSV-2-GFP at an MOI of 5 
PFU/cell. Supernatants and cells were collected at 24 hpi, and thereafter, the viral 
yield of samples was analyzed using plaque assays. (A) The viral yields produced by 
HeLa cells infected with WT HSV-2-GFP or DelgJ HSV-2-GFP. (B) The expression 
level of gD in the parallel samples of (A) was determined by western blot where actin 
was used as a loading control. Molecular weight standards in kilodaltons are shown 
on the left. (C) The viral yields produced by ARPE-19 cells infected with WT 
HSV-2-GFP or DelgJ HSV-2-GFP. (D) The expression level of gD in the parallel 
samples of (C) was determined by western blot where actin was used as a loading 
control. Molecular weight standards in kilodaltons are shown on the left. Data shown 
are mean  SD of three independent experiments with each condition performed in 
triplicate (A and C). One representative experiment out of three is shown (B and D). 
** represents P<0.01. 
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Fig. 5. HSV-2 gJ is important for plaque and syncytia formation. Vero and HeLa 
cells were infected with DelgJ HSV-2-GFP or WT HSV-2-GFP at an extremely low 
MOI (~80 PFU/1×10
6
 cells). In parallel, VgJ2 or HgJ2 cells were infected with RgJ 
HSV-2-GFP at a low MOI (~80 PFU/1×10
6
 cells). After removal of the inoculum, 
cells were maintained in growth medium with anti-HSV-2 antibody (Abnova) at a 
dilution of 1:1000 to neutralize extracellular HSV-2. Plaques and syncytia formation 
were photographed and the plaque areas were compared after 48 h incubation at 37°C. 
(A) The morphology of plaques on Vero and VgJ2 monolayers infected with WT 
HSV-2-GFP, DelgJ HSV-2-GFP or RgJ HSV-2-GFP. (B) The statistics of relative 
plaque area on Vero and VgJ2 monolayers infected with WT HSV-2-GFP, DelgJ 
HSV-2-GFP or RgJ HSV-2-GFP. Data shown are mean  SD of three independent 
experiments. “ ns” represents not significant, *** represents P<0.001. (C) 
Representative fields of plaque and syncytia formation acquired by fluorescence 
microscopy on Vero or HeLa monolayers infected with WT HSV-2-GFP or DelgJ 
HSV-2-GFP, and VgJ2 or HgJ2 monolayers infected with RgJ HSV-2-GFP. The green 
fluorescence represents HSV-2-infected cells. Nuclei were stained with Hoechst 
33342 (blue). Representative confocal images from three independent experiments are 
shown. Scale bars in all panels represent 50 μm.  
 
Fig. 6. HSV-2 gJ-mediated cell-to-cell spread leads to increased virus production. 
HeLa, ARPE-19 or SH-SY5Y cells were infected with DelgJ HSV-2-GFP or WT 
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HSV-2-GFP at very low MOI (~80 PFU/1×10
6
 cells). In parallel, HgJ2, AgJ2 or 
SHgJ2 cells were infected with RgJ HSV-2-GFP at a low MOI (~80 PFU/1×10
6
 cells). 
The ratio of GFP
+
 cells, viral genomic DNA and virus production were compared 
after 48 h incubation at 37°C. (A) The ratio of GFP
+
 cells in the HeLa, ARPE-19, 
SH-SY5Y, HgJ2, AgJ2 or SHgJ2 cells infected with DelgJ HSV-2-GFP, WT 
HSV-2-GFP or RgJ HSV-2-GFP was analyzed by flow cytometry. (B) The viral 
genomic DNA of the parallel samples of (A) was detected by relative quantitative 
PCR. (C) The virus production of the parallel samples of (A) was detected by plaque 
assay. Data shown are mean  SD of three independent experiments with each 
condition performed in triplicate. “ns” represents not significant, ** represents 
P<0.01, and *** represents P<0.001. 
 
Fig. 7. HSV-2 gJ promotes cell-to-cell spread among epithelial cells or from 
epithelial to neuronal cells. HeLa or ARPE-19 cells were infected with the same 
amount of DelgJ HSV-2-GFP or WT HSV-2-GFP at an MOI of 10 for 2h. In parallel, 
HgJ2 and AgJ2 cells were infected with RgJ HSV-2-GFP at an MOI of 10 for 2h. 
After digestion by trypsin, 100 cells per samples were taken out followed by 
co-cultivation with HeLa, ARPE-19, HgJ2, AgJ2, SH-SY5Y or SHgJ2 cells which 
were labeled with CellTracker Blue fluorescence dye for 2 days. HSV-2 transmission 
from infected to uninfected cells was subsequently quantified by flow cytometry. The 
CellTracker Blue
+
 GFP
+
 populations represent the newly infected cells. (A) HSV-2 
transmission from infected HeLa to uninfected HeLa cells or from infected HgJ2 to 
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uninfected HgJ2 cells was quantified by flow cytometry. (B) The ratio of the 
CellTracker Blue
+
 GFP
+
 populations from three independent experiments. (C) The 
virus production in the parallel samples of (B) was determined by plaque assay. (D) 
HSV-2 transmission from infected ARPE-19 to uninfected ARPE-19 cells or from 
infected AgJ2 to uninfected AgJ2 cells was quantified by flow cytometry. (E) The 
ratio of the CellTracker Blue
+
 GFP
+
 populations from three independent experiments. 
(F) The virus production in the parallel samples of (E) was determined by plaque 
assay. (G) HSV-2 transmission from infected ARPE-19 to uninfected SH-SY5Y cells 
or from infected AgJ2 to uninfected SHgJ2 cells was quantified by flow cytometry. (H) 
The ratio of the CellTracker Blue
+
 GFP
+
 populations from three independent 
experiments. (I) The virus production in the parallel samples of (H) was determined 
by plaque assay. Data shown are mean  SD of three independent experiments with 
each condition performed in triplicate (B, C, E, F, H and I). One representative 
experiment out of three is shown (A, D and G). “ns” represents not significant, * 
represents P<0.05, ** represents P<0.01, and *** represents P<0.001. 
 
Fig. 8. HSV-2 gJ likely functions as a regulator to increase viral protein 
expression and virus production. (A) HSV-2 gJ enhances the expression of HSV-2 
immediate early proteins ICP0, ICP22, ICP27 and late protein gB. 293T cells were 
cotransfected with pcDNA3.1, pgL-flag or pgJ-flag together with plasmid expressing 
immediate early proteins ICP0, ICP22, ICP27 or late protein gB. The expression level 
of ICP0-flag, ICP22-flag, ICP27-flag and gB in gJ-flag, gL-flag or control pcDNA3.1 
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transfected cells was measured by western blot where actin was used as a loading 
control. Molecular weight standards in kilodaltons are shown on the left. (B) The 
correlation between the dose of gJ and the expression level of ICP27 was analyzed by 
western blot where actin was used as a loading control. Molecular weight standards in 
kilodaltons are shown on the left. (C) The expression level of p24 in supernatants and 
cell lysates was detected by ELISA. 293T cells were cotransfected with pcDNA3.1, 
pgL-flag or pgJ-flag together with plasmid containing HIV-1 genome (pNL4-3). At 
48h post transfection, supernatants and cells were harvested separately. The 
expression level of p24 in supernatants and cell lysates was detected by ELISA. (D) 
HIV-1 production in supernatants was analyzed in an infection assay using 
supernatants containing HIV-1 to infect TZM-bl cells. (E) The expression level of 
NS3 in gJ-expressing cells, gL-expressing cells or control cells. 293T cells were 
cotransfected with plasmid expressing JEV NS3 and pcDNA3.1, pgL-flag or pgJ-flag. 
At 24h post transfection, the expression level of NS3 in cell lysates was detected by 
western blot where actin was used as a loading control. Molecular weight standards in 
kilodaltons are shown on the left. (F) The virus production of JEV in gJ-expressing 
cells, gL-expressing cells or control cells. HeLa cells transfected with control 
pcDNA3.1, pgL-flag or pgJ-flag were infected with JEV at an MOI of 10 PFU/cell. At 
24hpi, the viral yield was measured by plaque assay. One representative experiment 
out of three is shown (A, B and E). Data shown are mean  SD of three independent 
experiments with each condition performed in triplicate (C, D and F). “ns” represents 
not significant, ** represents P<0.01 and *** represents P<0.001. 
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